Position in HLN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$379,368
+$332,045 QoQ
Shares Held
37,899
+579.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026EntryPoint Capital, LLC holds $4,087,521 across 11 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,704 | $883,184 | |
| 2 | ZTS |
Zoetis Inc.
|
5,448 | $644,008 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
96,210 | $558,018 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
21,268 | $480,656 | |
| 5 | HLN |
Haleon plc
This page
|
37,899 | $379,368 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
86,874 | $304,927 | |
| 7 | AKBA |
Akebia Therapeutics, Inc.
|
201,749 | $280,431 | |
| 8 | SIGA |
Siga Technologies Inc
|
38,200 | $204,370 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $379,368 | 37,899 | Shares | Sole | 2026-05-14 | |
| 2024-03-31 | $47,323 | 5,574 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $82,769 | 10,057 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||